About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 462589, 5 pages
http://dx.doi.org/10.1155/2013/462589
Research Article

Bleomycin Loaded Magnetite Nanoparticles Functionalized by Polyacrylic Acid as a New Antitumoral Drug Delivery System

1Department of Orthodontics, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology, Guangdong, Guangzhou 510055, China
2State Key Laboratory of Optoelectronic Materials and Technologies, Guangdong Provincial Key Laboratory of Photovoltaics Technologies, School of Physics and Engineering, Institute for Solar Energy Systems, Sun Yat-sen University, Guangzhou 510275, China

Received 1 May 2013; Accepted 8 July 2013

Academic Editor: Narasimha Murthy

Copyright © 2013 Yue Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Moeller, K. Ask, D. Warburton, J. Gauldie, and M. Kolb, “The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?” International Journal of Biochemistry & Cell Biology, vol. 40, no. 3, pp. 362–382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Jin, Y. Jin, J. Wennerberg, B. Rosenquist, and F. Mertens, “Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients,” Mutation Research, vol. 652, no. 1, pp. 30–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Q. Luo and F. Zhao, “How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases,” Journal of Cranio-Maxillofacial Surgery, vol. 39, no. 7, pp. 482–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. G. Gobbi and M. Federico, “What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?” Critical Reviews in Oncology/Hematology, vol. 82, no. 1, pp. 18–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kurokawa, M. Suda, T. Okuda et al., “Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice,” Pulmonary Pharmacology & Therapeutics, vol. 23, no. 5, pp. 425–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Azambuja, J. F. Fleck, R. G. Batista, and S. S. Menna Barreto, “Bleomycin lung toxicity: who are the patients with increased risk?” Pulmonary Pharmacology & Therapeutics, vol. 18, no. 5, pp. 363–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. McGrath, A. Webb, and K. Walker-Bone, “Bleomycin-induced Raynaud’s phenomenon after single-dose exposure: risk factors and treatment with intravenous iloprost infusion,” Journal of Clinical Oncology, vol. 31, no. 4, pp. e51–e52, 2013. View at Publisher · View at Google Scholar
  8. K. Adriane, J. Huang, G. Ding, J. Chen, and Y. Liu, “Self assembled magnetic PVP/PVA hydrogel microspheres; magnetic drug targeting of VX2 auricular tumours using pingyangmycin,” Journal of Drug Targeting, vol. 14, no. 4, pp. 243–253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Kavaz, S. Odabaš, E. Güven, M. Demirbilek, and E. B. Denkbaš, “Bleomycin loaded magnetic chitosan nanoparticles as multifunctional nanocarriers,” Journal of Bioactive and Compatible Polymers, vol. 25, no. 3, pp. 305–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Han, H.-T. Wang, H.-Y. Liu, H. Hong, W. Lv, and Z.-H. Shang, “Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies,” International Journal of Pharmaceutics, vol. 398, no. 1-2, pp. 130–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Arruebo, R. Fernández-Pacheco, M. R. Ibarra, and J. Santamaría, “Magnetic nanoparticles for drug delivery,” Nano Today, vol. 2, no. 3, pp. 22–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Díaz-Rodríguez and M. Landin, “Smart design of intratumoral thermosensitive β-lapachone hydrogels by Artificial Neural Networks,” International Journal of Pharmaceutics, vol. 433, no. 1-2, pp. 112–118, 2012. View at Publisher · View at Google Scholar
  13. S. S. Chakravarthi, S. De, D. W. Miller, and D. H. Robinson, “Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles,” International Journal of Pharmaceutics, vol. 383, no. 1-2, pp. 37–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. L. A. Nagahara, M. Ferrari, and P. Grodzinski, “Nanofunctional materials in cancer research: challenges, novel methods, and emerging applications,” MRS Bulletin, vol. 34, no. 1, pp. 406–414, 2009. View at Publisher · View at Google Scholar
  15. H. Wang, J. Wei, C. Yang et al., “The inhibition of tumor growth and metastasis by self-assembled nanofibers of taxol,” Bioma Terials, vol. 33, no. 24, pp. 5848–5853, 2012. View at Publisher · View at Google Scholar
  16. R. Hao, R. Xing, Z. Xu, Y. Hou, S. Goo, and S. Sun, “Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles,” Advanced Materials, vol. 22, no. 25, pp. 2729–2742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Sui, Y. Cui, Y. Nie, G.-M. Xia, G.-X. Sun, and J.-T. Han, “Surface modification of magnetite nanoparticles using gluconic acid and their application in immobilized lipase,” Colloids and Surfaces B: Biointerfaces, vol. 93, pp. 24–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. T. K. Jain, S. P. Foy, B. Erokwu, S. Dimitrijevic, C. A. Flask, and V. Labhasetwar, “Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice,” Biomaterials, vol. 30, no. 35, pp. 6748–6756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Ge, Y. Hu, and Y. Yin, “Highly tunable superparamagnetic colloidal photonic crystals,” Angewandte Chemie, vol. 46, no. 39, pp. 7428–7431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Shuji, K. Koki, O. Yumi, B. Toshiaki, and K. Yoshinobu, “Therapeutic method of administering pharmaceutical titanium dioxide composite and light irradiation,” Japanese, 20110014245 [AA61K3174FI], 2013, http://www.faqs.org/patents/app/20110014245#b#ixzz2RzoIfzXF.
  21. Y. Xu, L. Zhuang, H. Lin, H. Shen, and J. W. Li, “Preparation and characterization of polyacrylic acid coated magnetite nanoparticles functionalized with amino acids,” Thin Solid Films, 2013. View at Publisher · View at Google Scholar
  22. X. Huang, L. Li, T. Liu et al., “The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo,” ACS Nano, vol. 5, no. 7, pp. 5390–5399, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. K. Gupta and S. Wells, “Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies,” IEEE Transactions on Nanobioscience, vol. 3, no. 1, pp. 66–73, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Milton Harris and R. B. Chess, “Effect of pegylation on pharmaceuticals,” Nature Reviews Drug Discovery, vol. 2, no. 3, pp. 214–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Lv, G. Ding, J. Zhai, Y. Guo, G. Nie, and L. Xu, “A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy,” Colloids and Surfaces B: Biointerfaces, vol. 16, no. 110, pp. 411–418, 2013. View at Publisher · View at Google Scholar